Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07578324 | TENS During Transperineal Prostate Biopsy(TENS 2) | recruiting | N/A | 140 | Medical University of GdanskOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT07593092 | Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors | recruiting | Phase 1 | 90 | Xencor, Inc.INDUSTRY | 1 | Aug 13, 2026 | clinicaltrials |
| NCT07757490 |
| Sonablate HIFU International Registry for PC & BPH Patients(SONAFUSION) |
| recruiting |
| — |
| 10,000 |
| SonablateINDUSTRY |
| 1 |
| Aug 13, 2026 |
| clinicaltrials |
| NCT07762911 | Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)(Visioning III) | recruiting | N/A | 300 | University Hospital, Basel, SwitzerlandOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT04489719 | Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer | recruiting | — | 48 | University of WashingtonOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05613894 | Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer(CaboLu) | recruiting | Phase 1 | 33 | University of UtahOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05923684 | NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making | recruiting | N/A | 30 | Cedars-Sinai Medical CenterOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06072911 | Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer(CONTROL4LIFE) | recruiting | N/A | 106 | University of AlbertaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06543576 | External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer | recruiting | Phase 1 / Phase 2 | 35 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06840886 | A Study of PHST001 in Advanced Solid Tumors | recruiting | Phase 1 | 272 | Pheast TherapeuticsINDUSTRY | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06851429 | Ovarian Cancer Identification on CT Using Deep Learning | recruiting | — | 12,578 | Chang Gung Memorial HospitalOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07382583 | Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer | recruiting | — | 270 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07546500 | A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression(ASPENOVA) | recruiting | Phase 3 | 420 | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncINDUSTRY | 12 | Aug 12, 2026 | clinicaltrials |
| NCT07760012 | 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors(SORB-PET) | recruiting | N/A | 50 | Peking University Third HospitalOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06236139 | Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 48 | Fred Hutchinson Cancer CenterOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT06242470 | A Study of MGC026 in Participants With Advanced Solid Tumors | recruiting | Phase 1 | 250 | MacroGenicsINDUSTRY | 3 | Aug 11, 2026 | clinicaltrials |
| NCT06257693 | Enzalutamide Implants (Enolen) in Patients With Prostate Cancer | recruiting | Phase 1 | 45 | Alessa Therapeutics Inc.INDUSTRY | 1 | Aug 11, 2026 | clinicaltrials |
| NCT06306612 | CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer(CREATIVE) | recruiting | N/A | 192 | RenJi HospitalOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT06358469 | STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision(STRIVE) | recruiting | N/A | 249 | Canadian Cancer Trials GroupNETWORK | 2 | Aug 11, 2026 | clinicaltrials |
| NCT06469710 | A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients | recruiting | — | 50 | RenJi HospitalOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07336134 | PopSci CHW4CervixHealth | recruiting | N/A | 120 | Thomas Jefferson UniversityOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07755592 | miRNA Panel for PCa Diagnosis | recruiting | — | 500 | RenJi HospitalOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT00488878 | Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors | recruiting | — | 2,000 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT03824652 | WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy | recruiting | Phase 2 | 50 | Stephen FreedlandOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT05046080 | Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix | recruiting | — | 70 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT05372484 | Rice Technologies for Cervical Cancer Screening and Diagnosis | recruiting | N/A | 678 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 10, 2026 | clinicaltrials |
| NCT05832086 | Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes | recruiting | Phase 2 | 138 | Stephen FreedlandOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT05840484 | Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance | recruiting | — | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT06067841 | A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer | recruiting | Phase 1 | 140 | Bristol-Myers SquibbINDUSTRY | 3 | Aug 10, 2026 | clinicaltrials |
| NCT06549855 | PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer | recruiting | N/A | 10 | Peking University People's HospitalOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07336446 | A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs(ANDROMEDA) | recruiting | Phase 1 / Phase 2 | 300 | AstraZenecaINDUSTRY | 8 | Aug 10, 2026 | clinicaltrials |
| NCT07351110 | Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.(PINPOINT) | recruiting | N/A | 20 | University of FloridaOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07415681 | GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries | recruiting | Phase 2 | 116 | University of Maryland, BaltimoreOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07741968 | A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer | recruiting | N/A | 126 | City of Hope Medical CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07754929 | E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer Survivors(E-Mergir) | recruiting | N/A | 106 | Universidade do PortoOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT03719547 | Robot-assisted Approach to Cervical Cancer(RACC) | recruiting | N/A | 800 | Karolinska InstitutetOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT04251052 | A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer | recruiting | N/A | 1,956 | NRG OncologyOTHER | 3 | Aug 7, 2026 | clinicaltrials |
| NCT04291612 | Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease | recruiting | — | 1,715 | Memorial Sloan Kettering Cancer CenterOTHER | 5 | Aug 7, 2026 | clinicaltrials |
| NCT06580314 | Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer | recruiting | Phase 3 | 880 | NRG OncologyOTHER | 3 | Aug 7, 2026 | clinicaltrials |
| NCT07151391 | The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) | recruiting | Phase 2 | 86 | University of UtahOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT07184957 | Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer | recruiting | — | 1,000 | NYU Langone HealthOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT01050504 | Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | recruiting | — | 1,500 | University of WashingtonOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT05610852 | Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound | recruiting | N/A | 276 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06145633 | Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 2 | 15 | Fred Hutchinson Cancer CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06188520 | A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors(CYCAD-1) | recruiting | Phase 1 / Phase 2 | 564 | AstraZenecaINDUSTRY | 5 | Aug 6, 2026 | clinicaltrials |
| NCT06386887 | Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer | recruiting | N/A | 20 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06907446 | Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies | recruiting | N/A | 50 | University of California, DavisOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07144228 | Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer | recruiting | — | 300 | Duke UniversityOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07223385 | High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) | recruiting | Phase 2 | 80 | Cedars-Sinai Medical CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07455903 | Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT | recruiting | Phase 2 | 50 | Baptist Health South FloridaOTHER | 1 | Aug 6, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 13, 2026source: clinicaltrials